Drug Profile
Research programme: TRPM7 ion channel inhibitors - NoNO
Alternative Names: TRPM7 inhibitors - NaNOLatest Information Update: 28 Nov 2020
Price :
$50
*
At a glance
- Originator NoNO
- Class Anti-ischaemics; Antiglaucomas; Antineoplastics; Eye disorder therapies
- Mechanism of Action TRPM cation channel inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Cancer; Ischaemia; Traumatic brain injuries
- No development reported Glaucoma; Myocardial ischaemia
Most Recent Events
- 28 Nov 2020 No recent reports of development identified for preclinical development in Glaucoma in Canada
- 28 Nov 2020 No recent reports of development identified for preclinical development in Myocardial-ischaemia in Canada
- 08 Sep 2020 Preclinical trials in Cancer in Canada (unspecified route) (NoNo pipeline, September 2020)